is developing a new platform in cancer care
We come to work every day with one mission in mind: Help people win the fight against cancer. Our job is to create a world where cancer is treated without scalpels or needles and with as little recovery time as possible. We intend to beat cancer by leading the development of non-invasive, highly precise treatments at an affordable cost. Every day, we move closer to our goal.
HistoSonics’ Leadership in Histotripsy
EXCLUSIVE ACCESS to the core IP
Continue to ADD to IP
Deeply EXPERIENCED management, board, advisory teams
ADVANCING histotripsy commercial development, including clinical testing
And we are leading the revolution with Robotically Assisted Sonic Therapy.
Exclusive worldwide license from the University of Michigan, where histotripsy was invented
An expanding portfolio of patents, national phase filings and applications
Extensive know-how in methods, system design, clinical applications, fabrication and testing
HistoSonics has a significant advantage in intellectual property related to histotripsy: